- Home
- IPSC vs MGLD Comparison
IPSC vs MGLD Comparison
Compare IPSC & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- MGLD
- Stock Information
- Founded
- IPSC 2019
- MGLD 1996
- Country
- IPSC United States
- MGLD United States
- Employees
- IPSC N/A
- MGLD N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- MGLD Finance/Investors Services
- Sector
- IPSC Health Care
- MGLD Finance
- Exchange
- IPSC Nasdaq
- MGLD Nasdaq
- Market Cap
- IPSC 45.4M
- MGLD 44.8M
- IPO Year
- IPSC 2021
- MGLD N/A
- Fundamental
- Price
- IPSC $0.55
- MGLD $1.02
- Analyst Decision
- IPSC Strong Buy
- MGLD
- Analyst Count
- IPSC 6
- MGLD 0
- Target Price
- IPSC $3.00
- MGLD N/A
- AVG Volume (30 Days)
- IPSC 1.5M
- MGLD 12.3K
- Earning Date
- IPSC 11-13-2025
- MGLD 11-07-2025
- Dividend Yield
- IPSC N/A
- MGLD N/A
- EPS Growth
- IPSC N/A
- MGLD N/A
- EPS
- IPSC N/A
- MGLD N/A
- Revenue
- IPSC $113,337,000.00
- MGLD $29,207,000.00
- Revenue This Year
- IPSC $1,589.94
- MGLD N/A
- Revenue Next Year
- IPSC N/A
- MGLD N/A
- P/E Ratio
- IPSC N/A
- MGLD N/A
- Revenue Growth
- IPSC 4122.69
- MGLD N/A
- 52 Week Low
- IPSC $0.34
- MGLD $0.64
- 52 Week High
- IPSC $1.83
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- IPSC 52.98
- MGLD 50.12
- Support Level
- IPSC $0.46
- MGLD $0.90
- Resistance Level
- IPSC $0.56
- MGLD $1.11
- Average True Range (ATR)
- IPSC 0.04
- MGLD 0.07
- MACD
- IPSC 0.00
- MGLD 0.00
- Stochastic Oscillator
- IPSC 76.21
- MGLD 57.14
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.